Eli Lilly's proposal to acquire Orna Therapeutics sparks Australian review
MLex Summary: Eli Lilly and Company’s proposal to acquire 100 percent of the issued shares in Orna Therapeutics Holdings will be reviewed by Australia’s antitrust regulator. In a statement on Thursday,...To view the full article, register now.
Already a subscriber? Click here to view full article